January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Gene Study Reveals New Osteoarthritis Targets

"This study represents a major breakthrough for OA research by providing potential explanations for 13 OA GWAS risk loci."

Conexiant

January 07, 2025

Body Composition Linked to Quality of Life in OA

Researchers examined associations between body composition factors, such as fat and muscle mass, and health-related quality of life outcomes in patients with knee and hip osteoarthritis.

Conexiant

January 07, 2025

Which Diets Help Manage Joint Pain Best?

"The Mediterranean diet tops the list at 4.6/5.0 for managing arthritis symptoms," find out how specific foods reduce CRP, IL-6, and TNF-alpha.

Conexiant

December 27, 2024

More Aerobic Minutes Equals More Weight Loss

At 150 minutes per week, participants averaged a weight loss of 2.79 kg, while at 300 minutes per week, weight loss increased to 4.19 kg.

Conexiant

June 11, 2024

Omega-3 Supplementation and Its Effects on Osteoarthritis

Omega-3 supplementation has shown potential in reducing inflammation and improving symptoms in osteoarthritis, though further research is needed to confirm its efficacy.

Conexiant

July 10, 2024

OA Linked to Higher Multimorbidity Risk, Study

A 20-year study reveals that patients with osteoarthritis have a higher risk of severe multimorbidity, emphasizing the need for comprehensive health care strategies beyond joint health.

Conexiant

June 20, 2024

FDA Proposes Removal of Switching Study Requirement for Biosimilars

Explore the FDA's proposed changes for biosimilar drugs and their interchangeability, including expert insights on regulatory impacts and market dynamics.

Reuters

August 14, 2024

U.S. Adults’ Exposure to 6 Potentially Hepatotoxic Botanicals

A recent study found that approximately 15.6 million U.S. adults may be using botanicals with known liver toxicity, raising concerns about potential hepatotoxic risks and the lack of regulatory oversight.

Conexiant